Shares of NutriSystem Inc (NASDAQ:NTRI) have been given a consensus recommendation of “Buy” by the ten ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $68.11.

A number of equities analysts have recently commented on NTRI shares. DA Davidson reaffirmed a “buy” rating and issued a $79.00 price target (up from $64.00) on shares of NutriSystem in a report on Sunday, July 30th. Sidoti raised NutriSystem from a “neutral” rating to a “buy” rating and set a $60.00 price objective for the company in a research note on Monday, June 12th. B. Riley reissued a “buy” rating and set a $74.00 price objective on shares of NutriSystem in a research note on Friday, July 28th. Craig Hallum set a $80.00 price objective on NutriSystem and gave the company a “buy” rating in a research note on Thursday, July 27th. Finally, Lake Street Capital set a $73.00 price objective on NutriSystem and gave the company a “buy” rating in a research note on Thursday, July 27th.

In other NutriSystem news, insider Dawn M. Zier sold 29,100 shares of NutriSystem stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $54.00, for a total transaction of $1,571,400.00. Following the completion of the sale, the insider now owns 273,867 shares of the company’s stock, valued at $14,788,818. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Dawn M. Zier sold 30,000 shares of NutriSystem stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $52.71, for a total value of $1,581,300.00. Following the sale, the insider now directly owns 283,931 shares of the company’s stock, valued at approximately $14,966,003.01. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 106,221 shares of company stock valued at $5,633,245. Corporate insiders own 2.40% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. BlackRock Inc. lifted its stake in NutriSystem by 114,552.3% during the first quarter. BlackRock Inc. now owns 3,554,222 shares of the company’s stock worth $197,259,000 after purchasing an additional 3,551,122 shares during the last quarter. Renaissance Technologies LLC lifted its stake in NutriSystem by 1.2% during the first quarter. Renaissance Technologies LLC now owns 2,487,900 shares of the company’s stock worth $138,078,000 after purchasing an additional 30,000 shares during the last quarter. Vanguard Group Inc. lifted its stake in NutriSystem by 50.3% during the second quarter. Vanguard Group Inc. now owns 2,458,686 shares of the company’s stock worth $127,974,000 after purchasing an additional 823,221 shares during the last quarter. Prudential Financial Inc. lifted its stake in NutriSystem by 73.7% during the second quarter. Prudential Financial Inc. now owns 1,302,467 shares of the company’s stock worth $67,794,000 after purchasing an additional 552,420 shares during the last quarter. Finally, Copper Rock Capital Partners LLC lifted its stake in NutriSystem by 74.5% during the second quarter. Copper Rock Capital Partners LLC now owns 1,243,535 shares of the company’s stock worth $43,088,000 after purchasing an additional 530,805 shares during the last quarter. 92.59% of the stock is owned by hedge funds and other institutional investors.

NutriSystem (NTRI) traded up 1.44% during mid-day trading on Wednesday, hitting $52.75. The stock had a trading volume of 83,513 shares. The firm’s 50-day moving average is $53.23 and its 200 day moving average is $52.80. NutriSystem has a 12 month low of $28.72 and a 12 month high of $67.95. The company has a market cap of $1.57 billion, a price-to-earnings ratio of 32.68 and a beta of 1.15.

NutriSystem (NASDAQ:NTRI) last posted its quarterly earnings results on Wednesday, July 26th. The company reported $0.80 EPS for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.18. NutriSystem had a return on equity of 48.41% and a net margin of 7.60%. The firm had revenue of $194.90 million during the quarter, compared to analyst estimates of $180.75 million. During the same period last year, the company earned $0.54 earnings per share. The business’s revenue for the quarter was up 30.1% on a year-over-year basis. Equities analysts anticipate that NutriSystem will post $1.91 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “NutriSystem Inc (NTRI) Receives Average Recommendation of “Buy” from Brokerages” was posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/09/20/nutrisystem-inc-ntri-receives-average-recommendation-of-buy-from-brokerages.html.

About NutriSystem

Nutrisystem, Inc is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company’s program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy.

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem Inc and related companies with MarketBeat.com's FREE daily email newsletter.